Skip to main content
Caplight Logo









Guzip Biomarkers Corporation

Guzip Biomarkers Corporation

Private
TaiwanHealthcare & Life Scienceshttps://guzipbio.com

Last Round

Seed

Mar 1, 2019

Company Overview

Guzip Biomarkers Corporation is a biotechnology company that develops DNA methylation-based diagnostic tools for the detection of endometrial cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

molecular diagnosticscervical cancer screeningDNA methylationepigenetic biomarkersin vitro diagnosticsIVDlaboratory developed testLDTcancer diagnosticsliquid biopsygynecological oncologydiagnostic kitsprecision medicineearly cancer detectionbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guzip Biomarkers Corporation Comparables

Compare Guzip Biomarkers Corporation with similar companies based on industry and business-model similarity.

Guzip Biomarkers Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iStat Biomedical Co., Ltd.
89%
Epitype GmbH
89%
Self-screen B.V.
86%

Guzip Biomarkers Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2019

Key People

Founding team and executive leadership

Polly Lin

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 53% MoM, reaching 1.4K.

  • Apr 18, 2025

    Monthly visitors increased 153% MoM.

Guzip Biomarkers Corporation Filings

Explore SEC and related filing metadata, where available.

Guzip Biomarkers Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Guzip Biomarkers Corporation's valuation, stock price, and market status.

Is Guzip Biomarkers Corporation a public or private company?

Guzip Biomarkers Corporation is a private company.

What is the current stock price of Guzip Biomarkers Corporation?

Guzip Biomarkers Corporation is a private company with no public stock price. Caplight tracks Guzip Biomarkers Corporation's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Guzip Biomarkers Corporation worth (valuation)?

Valuation information for Guzip Biomarkers Corporation is not publicly available.

Can I buy Guzip Biomarkers Corporation stock?

Guzip Biomarkers Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Guzip Biomarkers Corporation's last funding round?

Funding round information for Guzip Biomarkers Corporation is not publicly available.

Who are the main investors in Guzip Biomarkers Corporation?

Investor information for Guzip Biomarkers Corporation is not publicly disclosed.

Will Guzip Biomarkers Corporation IPO soon?

No public IPO plans have been announced for Guzip Biomarkers Corporation.

How can I track Guzip Biomarkers Corporation secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guzip Biomarkers Corporation's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaiwan
Employee Range2
Year Founded2018
Last FundingMar 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?